US Patent 6838089 Antigen delivery system and method of production
Patent 6838089 was granted and assigned to AstraZeneca on January, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+617 characters)
Article
Patent abstract
The present invention concerns polymer particle vaccine delivery systems in which a water insoluble protein antigen, e.g. a lipidated HpaA protein, is incorporated with particles comprising a polymer matrix. The present invention also concerns a method for incorporating such a water insoluble protein antigen with a polymer matrix in order to produce a polymer particle vaccine delivery system. In addition, the invention also provides a vaccine composition comprising the polymer particle delivery system. The vaccine can be used to treat and/or reduce the risk of for example Helicobacter infection.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Anette Larsson0
Erik Söderlind0
Hans Carlsson0
Date of Patent
January 4, 2005
0Patent Application Number
093084350
Date Filed
April 9, 1999
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6838089 Antigen delivery system and method of production
Find more entities like US Patent 6838089 Antigen delivery system and method of production
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
